Hasil Pencarian  ::  Simpan CSV :: Kembali

"ABSTRACTThis case study aim to evaluate the response of steroid treatment for autoimmune endocarditis. Valvular heart disease is relatively rising in both congenital and acquired cases, but the autoimmune endocarditis remains rare. In this case, a 34 year old woman with clinical manifestation resembling systemic lupus erythematosus (SLE) is diagnosed with Libman-sacks Endocarditis. After six months of steroid treatment, her clinical manifestations and heart structure improved."

"Latar Belakang. Sejak laporan pertama ensefalitis antireseptor N-methyl-D-aspartate (NMDA) pada 2007, prevalensi ensefalitis autoimun (EA) serupa dengan ensefalitis infeksi (EI). Sayangnya, heterogenitas klinis EA, serupanya klinis dengan EI, penyakit autoimun seperti neuropsikiatrik lupus eritematosus sistemik, atau penyakit psikiatrik menjadi tantangan deteksi awal dan tatalaksana EA. Keterlambatan berhubungan dengan perburukan luaran, sedangkan kekurang-tepatan menerapi EI sebagai EA dapat mengeksaserbasi infeksi. Studi ini bertujuan mengenali karakteristik EA, khususnya ensefalitis antireseptor NMDA definit sebagai EA tersering, di era keterbatasan ketersediaan penunjang definitif di Indonesia.Metode. Studi kohort retrospektif dengan rekam medis di RSUPN dr. Cipto Mangunkusumo dilakukan pada curiga EA yang menjalani pemeriksaan antireseptor NMDA cairan otak sejak Januari 2015-November 2022. Karakteristik klinis dan penunjang EA, EA seropositif NMDA, dan luarannya dinilai. Analisis univariat dan bivariat dilakukan sesuai kebutuhan.Hasil. Dari 102 subjek yang melalui kriteria inklusi dan eksklusi, terdapat 14 EA seropositif dan 32 seronegatif NMDA. Temuan klinis EA terbanyak adalah gangguan psikiatri dan tidur (85,7%), gangguan kesadaran (78,3%), prodromal (76,1%), dan bangkitan (70,6%). Karakteristik penunjang EA adalah inflamasi sistemik (75,0%), inflamasi cairan otak (69,2%), abnormalitas MRI (57,9%) dominan inflamasi (42,2%), dan abnormalitas EEG (89,5%). Karakteristik klinis EA seropositif NMDA adalah psikosis (76,9% vs 24,1%, p=0,002), delirium (71,4% vs 40,6%, p=0,06), bangkitan (71,4% vs 46,7%, p=0,12), takikardia (55,6% vs 17,6%, p=0,08), dan gangguan otonom lainnya (55,6% vs 23,5%, p=0,19), sedangkan klinis EA seronegatif NMDA adalah somnolen (34,4% vs 7,1%, p=0,07) dan defisit neurologis fokal (31,3% vs 7,1%, p=0,13). Leukositosis dan pleositosis cairan otak dengan dominasi mononuklear secara signifikan lebih ditemukan pada EA seropositif NMDA. Sebanyak 10,9% subjek meninggal.Kesimpulan. Karakteristik klinis EA adalah gangguan psikiatri dan tidur, gangguan kesadaran, prodromal, dan bangkitan. Psikosis, delirium, bangkitan, dan disfungsi otonom cenderung lebih ditemukan pada EA seropositif NMDA. Inflamasi sistemik, cairan otak, MRI, dan abnormalitas EEG sering ditemukan pada EA, terutama seropositif NMDA. 

---

Background. Since the first report of N-methyl-D-aspartate receptor (NMDAR) encephalitis in 2007, the prevalence of autoimmune encephalitis (AE) was similar to infectious encephalitis (IE). Unfortunately, heterogenities of EA as well as similarities in the manifestation to IE, other autoimmune diseases including neuropsychiatric systemic lupus erythematosus, or psychiatric diseases compromised the early detection and management of EA. This delay correlated with worse outcome whereas the inaccuracy in treting IE as AE may exacerbate infection. This study aimed to describe the characteristics of EA, particularly definitive NMDAR encephalitis as the most common, in the era of limited availability of definitive ancillary test in Indonesia.

Methods. Retrospective study using medical records at Dr. Cipto Mangunkusumo National Center General Hospital was conducted for suspected EA cases tested for cerebrospinal fluid NMDAR autoantibody test from January 2015 to November 2022. Clinical, ancillary characteristics, and concordance between clinical diagnosis and diagnostic criteria were assessed. Univariate, bivariate, and multivariate analysis were perfomed as needed.

Result. Of 102 subjects following inclusion and exclusion criteria, there were 14 seropositive and 32 seronegative NMDA subject. Clinical characterstics of AE were psychiatric and sleep disorder (85,7%), altered consciousness (78.3%), prodromal (76.1%), and seizure (70.6%). Ancillary characteristics of AE were systemic inflammation (75.0%), cerebrospinal fluid inflammation (69.2%), MRI abnormalities (57.9%) with inflammatory predominance (42.2%), and EEG abnormalities (89.5%). Seropositive NMDA characteristics were psychosis (76.9% vs 24.1%, p=0.002), delirium (71.4% vs 40.6%, p=0.06), seizure (71.4% vs 46.7%, p=0.12), tachycardia 955.6% vs 17.6%, p=-0.08), and other autonomic disorder (55.6% vs 23.5% p=0.19) whereas seronegative NMDA characteristics were somnolence (34.4% vs 7.1%, p=0.07) and focal neurologic deficit (31.3% vs 7.1%, p=0.13). Leukocytosis and cerebrospinal fluid pleocytosis with mononuclear predominance were significantly found in seropositive NMDA AE. The mortality rate was 10.9%.

Conclusion. Clinical characteristics of AE were psychiatric and sleep disorder, altered consciousness, prodromal, and seizure. Psychosis, delirium, seizure, and autonomic dysfunction tended to be found in seropositive NMDA AE. Inflammation in systemic, cerebrospinal fluid, and MRI findings as well as EEG abnormalities commonly occurred in AE, especially seropositive NMDA."

"ABSTRAKLatar Belakang: Penyakit autoimun terjadi karena tubuh tidak mampu untuk mengenali sel atau jaringan tubuh sendiri, sehingga tubuh memberikan respons seperti proses eliminasi antigen terhadap sel atau jaringan tubuh sendiri. Berbagai faktor risiko, antara lain genetik, lingkungan dan nutrisi berperan pada perkembangan penyakit autoimun. Saat penyakit autoimun telah menimbulkan gejala, pasien memiliki risiko mendapat nutrisi yang tidak adekuat. Selain itu, kondisi autoimun akan menimbulkan respons inflamasi terus-menerus di dalam tubuh. Bila kondisi ini terus berlanjut akan menyebabkan peningkatan status metabolisme, status nutrisi, status imun dan menimbulkan gangguan kapasitas fungsional pada pasien. Pasien dengan penyakit autoimun harus didukung dengan edukasi dan mendapat terapi nutrisi yang tepat dan adekuat, terutama saat menjalani proses terapi sehingga kebutuhan nutrisi dapat terpenuhi sesuai dengan kondisi pasien. Metode: Laporan serial kasus ini menguraikan empat kasus penyakit autoimun. Dua kasus merupakan kasus neurologi, sementara dua kasus lain adalah kasus penyakit kulit. Dua pasien memiliki status nutrisi malnutrisi berat, satu pasien berat badan normal berisiko malnutrisi dan satu pasien obes I berisiko malnutrisi. Terapi nutrisi sesuai mengacu pada diet seimbang. Semua pasien mendapat terapi nutrisi sejak dikonsulkan ke Departemen Medik Ilmu Gizi hingga hari terakhir perawatan di RS. Asupan energi dan protein diberikan meningkat bertahap sesuai dengan kondisi klinis dan toleransi pasien. Suplementasi mikronutrien diberikan kepada pasien. Pemantauan pasien meliputi keluhan subjektif, hemodinamik, analisis dan toleransi asupan, pemeriksaan laboratorium, antropometri, imbang cairan, dan kapasitas fungsional. Hasil: Selama pemantauan di RS, asupan pasien dapat mencapai kebutuhan energi total dan mikronutrien diterima oleh pasien. Perbaikan klinis dan perbaikan kapasitas fungsional terjadi pada 3 pasien. Satu pasien mengalami perburukan dan meninggal akibat sepsis pada hari perawatan ke-33. Kesimpulan: Terapi nutrisi pada pasien autoimun dapat mendukung proses pengobatan berupa perbaikan kapasitas fungsional dan lama rawat 3 pasien.

---

ABSTRACTObjective Autoimmune disease is a condition of body inability to recognize the cells or tissues itself. It will response as antigen elimination process against the cells or tissue itself. Autoimmune risk factors, such as genetic, enviromental and nutrients play a role in the development of autoimmune diseases. When the symptoms occur, the patient have a risk of inadequate nutrition. In addition, autoimmune condition will cause continuous inflammatory response. This situation will increase patients rsquo s metabolic, nutritional, and immune status. Thus, reduce the patient rsquo s functional capacity. Patient with autoimmune disease should be supported by appropriate and adequate nutrition education and therapy, especially during the therapeutic process so that the nutrition requirements can be fulfilled according to the patient 39 s condition. Methods These case report outlines four cases of autoimmune disease. Two cases are cases of neurology, while the other two cases are cases of skin disease. Two patients had severe malnutrition, one normoweight patient at risk for malnutrition and one obese patient at risk of malnutrition. Management of appropriate nutrition refers to a balanced diet. All patients received nutritional therapy from the Clinical Nutrition Department until the last day of hospitalization. The energy and protein intake increase gradually in accordance with improved clinical conditions and patient rsquo s tolerance. Supplementation of micronutrients is given to the patient. Patient monitoring includes subjective, hemodynamics, analysis and tolerance of intake, laboratory examination, anthropometry, fluid balance, and functional capacity Results During hospital monitoring, the patient 39 s nutrition intake can achieve the total energy and protein requirement as well as the micronutrients. Clinical condition and functional capacity improvements occurred in 3 patients. One patient had worsening condition and died due to sepsis in the 33rd day of treatment. Conclusion Nutritional therapy for patients with autoimmune disease can support the treatment process in improvement of functional capacity and length of stay."

"Penyakit autoimun berisiko mengalami komplikasi yang berujung pada sakit kritis. Hal ini dapat menyebabkan peningkatan morbiditas dan mortalitas. Tata laksana nutrisi dapat membantu mencegah malnutrisi, meningkatkan status nutrisi, dan memperbaiki status metabolik, sehingga dapat memperbaiki luaran klinis, mempersingkat fase sakit kritis, dan lama rawat rumah sakit (RS). Pasien dalam serial kasus ini mengalami komplikasi penyakit autoimun yang menyebabkan pasien mengalami sakit kritis, danmembutuhkan perawatan intensif. Keempat pasien adalah perempuan, dengan rentang usia 19−37 tahun, dengan status gizi obes 1 pada dua pasien, dan malnutrisi berat pada pasien lainnya. Dua dari empat pasien mendapatkan tata laksana nutrisi sejak awal fase sakit kritis, sedangkan sisanya setelah lebih dari tujuh hari perawatan intensif. Terapi medik gizi diberikan selama berada di ruang perawatan intensif, meliputi pemenuhanenergi, makronutrien, dan mikronutrien, sesuai kondisi klinis dan toleransi pasien. Asupan energi pada keempat pasien saat perawatan intensif mencapai 25−47 kkal/kg BB/hari, dengan asupan protein tertinggi sebesar 1,4−2,7 g/kg BB/hari. Durasi pemakaian ventilator mekanik, hari perawatan intensif dan RS terpanjang, terdapat pada pasien yang mengalami malnutrisi berat. Tiga dari empat pasien dengan toleransi asupan yang baik mengalami perbaikan luaran klinis, peningkatan kapasitas fungsional,dan diizinkan untuk rawat jalan. Satu pasien pulang atas permintaan sendiri sebelum perbaikan kondisi klinis. Tingkat keparahan penyakit, komplikasi, dan status gizi pada pasien autoimun yang mengalami sakit kritis, mempengaruhi luaran klinis. Tata laksana nutrisi dapat meningkatkan status gizi, sehingga membantu memperbaiki kondisi klinis, menurunkan morbiditas dan mortalitas pasien

---

Autoimmune diseases pose risks for complications, leading to critical illnesses, thus increase the morbidity and mortality rate. Nutritional management can prevent malnutrition, improve metabolic and nutritional status, thereby, improve clinical outcomes, shorten critical illness phase, and reduce hospital length of stay. In these case series, all patients had autoimmune diseases with complications, leading to critically ill conditions that required intensive care. All patients were women, aged of 19−37 years. There were two patients with obesity and others with severe malnutrition. Two patients received nutritional management starting from the acute phase, while the rest were at the late period. Medical nutrition therapy was given while in the intensive care unit (ICU), including the energy fulfillment, macro- and micro-nutrients, according to the clinical condition and patient’s tolerance. The energy intake of patients during the critical ilness was 25−47 kcal/kg BW/day, with the protein intake was 1.4−2.7 g/kg BW/day. The longest duration of mechanical ventilator use, length of ICU and hospital stay, were found in patients who were severely malnourished. Three patients with good nutritional intake, had better improvement in clinical conditions, complications, and functional capacity. They were allowed to be discharged and followed up at outpatient unit, while one patient returned home on her own request, before required improvement of clinical conditions. Severity of the diseases, complications, and the nutritional status of autoimmune patients with critical illnesses affected overall clinical outcomes. Medical nutrition therapy can improve metabolic and nutritional status, thereby improve clinical conditions, reduce morbidity and mortality of the patient"

"Latar Belakang. Pasien autoimun rentan terhadap infeksi COVID-19 dan luaran yang lebih berat, sehingga penting untuk mendapat vaksinasi. Namun, terdapat kekhawatiran efek samping, kekambuhan penyakit, serta efektivitas dan imunogenitas vaksin. Tujuan. Mengetahui cakupan vaksinasi COVID-19 di Poli Alergi Imunologi RSCM dan faktor-faktor yang berhubungan. Metode. Studi potong lintang ini melibatkan 260 pasien autoimun dari Poli Alergi Imunologi RSCM periode Juli-Agustus 2023. Pengambilan data menggunakan kuesioner. Analisis bivariat dengan Uji Chi-Square atau Fischer dan analisis multivariat dengan regresi Poisson. Hasil. Cakupan vaksinasi COVID-19 pasien autoimun untuk dosis pertama 60%, dosis kedua 57.3%, dan dosis ketiga 40%. Melalui analisis bivariat, didapatkan faktor yang berhubungan dengan cakupan berupa pekerjaan tenaga kesehatan (PR 1,68; p < 0,001), rekomendasi dokter yang merawat (PR 6,47; p<0,001), dan skala persepsi pasien terhadap keparahan penyakit (p<0,001). Analisis multivariat menunjukkan hubungan antara rekomendasi dokter yang merawat (PR 4,67; p<0,001), pekerjaan tenaga kesehatan (PR 1,56; p=0,01), diagnosis SLE (PR 0,81; p=0,003) dan skala persepsi pasien terhadap keparahan penyakit (PR 0,88; p<0,001). Simpulan. Cakupan vaksinasi COVID-19 dosis pertama pada pasien autoimun di Poli Alergi-Imunologi RSCM adalah 60%. Studi ini menemukan hubungan cakupan vaksinasi dengan rekomendasi dokter yang merawat, pekerjaan sebagai tenaga kesehatan, diagnosis SLE, dan persepsi pasien terhadap keparahan penyakit.

---

Background. Autoimmune patients are susceptible to COVID-19 infection and severe outcomes, so it is important to receive vaccination. However, there are concerns about side effects, disease recurrence, and vaccine effectiveness and immunogenicity.

Objective. To explore uptake of COVID-19 vaccination at RSCM Allergy Immunology Clinic and related factors.

Method. This cross-sectional study involved 260 autoimmune patients from the RSCM Allergy Immunology Clinic for July-August 2023. Data was collected with questionnaire. Bivariate analysis with Chi-Square or Fischer Test and multivariate analysis with Poisson regression.

Results. COVID-19 vaccination coverage for autoimmune patients for the first dose is 60%, the second dose is 57.3%, and third dose is 40%. Through bivariate analysis, associated factors were health worker employment (PR 1.68; p < 0.001), recommendation of treating doctor (PR 6.47; p < 0.001), and patients’ perception of their illness (p< 0.001). Multivariate analysis showed association between recommendation of treating doctor (PR 4.67;p<0.001), health worker's occupation (PR 1.56;p=0.01), SLE diagnosis (PR 0.81;p=0.003) and the scale patient perception of disease severity (PR 0.88;p<0.001).

Conclusion. Coverage first dose COVID-19 vaccination in autoimmune patients at RSCM Allergy-Immunology Clinic is 60%. This study found association between recommendation of treating doctor, healthcare workers, SLE diagnosis, and patients’ perception of their illness."

"Latar belakang : Inflamatory Bowel disease (IBD) merupakan penyakit autoimun yang insidens dan prevalensinya meningkat terus setiap tahunnya. Modernisasi dan kemajuan industri suatu wilayah selalu diikuti dengan perubahan pola hidup termasuk pola diet cepat saji (western diet) yang tinggi protein dan karbohidrat serta rendah serat dan buah. Diet, dapat merubah komposisi mikrobiota usus (dysbiosis), suatu bakteri komensal yang menjaga homeostasis dan sistim imun mukosa usus sehingga dapat memicu timbulnya IBD serta peningkatan aktifitas penyakitnya (flare).IgG yang meningkat setelah makan, merupakan suatu antibody neutralisasi sebagai bagian toleransi imun pada orang sehat dimana pada IBD makanan dapat dikenali sebagai antigen yang melalui ikatan antigen-antibodi reaksi hypersensitivitas tipe III, kemungkinan dapat menyebabkan inflamasi usus terus menerus dan mempengaruhi aktifitas penyakit.Tujuan : Untuk mengetahui hubungan antara IgG antibodi spesifik makanan dan aktivitas penyakit klinis pada pasien IBDMetode: Studi potong lintang, melibatkan 113 pasien IBD yang diagnosisnya telah dikonfirmasi dengan kolonoskopi. Pada pasien yang setuju dilakukan pemeriksaan serum IgG spesifik makanan untuk 220 jenis makanan menggunakan teknik Elisa dan Immunoarray. Aktivitas klinis pada Kolitis Ulseratif (KU) dinilai menggunakan Indeks Mayo sedangkan pada Penyakit Crohn dinilai menggunakan Indeks Aktivitas Penyakit Chrons (Crohn Disease Activity Index)Hasil: Proporsi antibodi IgG spesifik makanan tertinggi pada kelompok penyakit Crohn adalah kacang polong (100%), barley (97,9%), telur (95,9%), susu (81,6%), jagung (75,5%), agar-agar (69,4). %), kacang mede (69,4%) gandum (67,3%), oat (61,2%) dan almond (59,2%), sedangkan pada Kolitis Ulseratif adalah jelai (98,4%), kacang polong (96,8%), putih telur (92,2%), jagung (82,8%), plum (78,1%), kacang mede (67,2%), susu sapi (65,6%), gelatin (59,4%), almond (50%), kacang merah (48,4%) dan gandum (46,9%). Dari 220 jenis antigen makanan, pada KU didapatkan korelasi negatif yang cukup kuat pada jenis kacang mede dengan r = -0,347 (p=0,041) dan kacang Arab dengan r = -0.473 ( p=0.017); sementara di kelompok PC didapatkan korelasi positif yang cukup kuat pada jenis jelai dengan r = 0,261 ( p= 0,042).Kesimpulan: Terdapat hubungan korelasi negative lemah antara antibodi IgG spesifik kacang mede, dan kacang Arab dengan aktifitas IBD, serta korelasi positive lemah antara antibody IgG spesifik jelai dengan aktivitas klinis IBD

---

Background : Inflammatory Bowel disease (IBD) is an autoimmune disease whose incidence and prevalence is increasing every year. Modernization and industrial progress of a region are always followed by changes in lifestyle, including a fast food diet (western diet) which is high in protein and carbohydrates and low in fiber and fruit. Diet, can change the composition of the gut microbiota (dysbiosis), a commensal bacteria that maintains homeostasis and the intestinal mucosal immune system so that it can trigger IBD and increase its disease activity (flare). IgG which increases after eating, is a neutralizing antibody as part of immune tolerance in humans. In healthy people, food IBD can be recognized as an antigen by triggering the antigen-antibody binding type III hypersensitivity reaction, possibly causing persistent intestinal inflammation and influencing disease activity.

Objective : To determine the relationship between food-specific IgG antibody and clinical disease activity in IBD patients

Methods: Cross-sectional study, involving 113 IBD patients whose diagnosis was confirmed by colonoscopy. In patients who agreed, food-specific IgG serum was examined for 220 types of food using the Elisa and Immunoarray technique. Clinical activity in Ulcerative Colitis (KU) was assessed using the Mayo Index while in Crohn's Disease was assessed using the Crohn Disease Activity Index.

Results: The highest proportion of food-specific IgG antibodies in the Crohn's disease group were peas (100%), barley (97.9%), eggs (95.9%), milk (81.6%), corn (75.5%), agar (69,4). %), cashews (69.4%) wheat (67.3%), oats (61.2%) and almonds (59.2%), while in Ulcerative Colitis were barley (98.4%), peas (96.8%), egg whites (92.2%), corn (82.8%), plums (78.1%), cashews (67.2%), cow's milk (65.6%), gelatin (59.4%), almonds (50%), kidney beans (48.4%) and wheat (46.9%). Of the 220 types of food antigens, the KU showed a strong negative correlation with cashew nuts with r = -0.347 (p=0.041) and chickpeas with r = - 0.473 (p=0.017); while in the PC group, there was a fairly strong positive correlation on the type of barley with r = 0.261 (p = 0.042).

Conclusion: There is a weak negative correlation between cashew and chickpea specific IgG antibodies and IBD activity, and a weak positive correlation between barley specific IgG antibodies and IBD clinical activity"

"Penyakit Graves merupakan penyakit autoimun yang melibatkan antibodi TSH-R dalam menstimulasi kelenjar tiroid sehingga terjadi sintesis dan sekresi hormon tiroid yang berlebih. Sebanyak 50% pasien penyakit Graves mengalami kekambuhan setelah terapi obat antitiroid selesai diberikan. Faktor genetik salah satunya polimorfisme gen FCLR3 rs7528684 diketahui berperan terhadap kejadian penyakit Graves. Namun, belum ada studi yang mengidentifikasi keterkaitan polimorfisme gen FCRL3 rs7528684 dengan kekambuhan penyakit Graves. Untuk itu, penelitian ini bertujuan untuk mengetahui hubungan polimorfisme gen FCRL3 rs7528684 terhadap kekambuhan penyakit Graves. Desain penelitian yang digunakan adalah studi cross sectional yang dilakukan pada 80 pasien penyakit Graves. Hasil isolasi DNA pasien dilakukan pemeriksaan genotyping dengan menggunakan metode tetra primer ARMS-PCR. Hasil penelitian menunjukkan terdapat 2 variasi genotip pada pasien penyakit Graves yaitu genotip GG (2,5%) dan genotip GA (97,5%). Pada kelompok kambuh, 100% memiliki genotip GA sehingga frekuensi alotip G dan alotip A masing-masing 50%. Sementara itu, pada kelompok tidak kambuh, didapatkan 6,1% genotip GG dan 93,9% gentoip GA dengan frekuensi alotip G dan alotip A yaitu 53,03% dan 46,97%. Berdasarkan hasil analisis uji statistik, disimpulkan bahwa tidak terdapat hubungan antara genotip dan alotip gen FCRL3 rs7528684 dengan kekambuhan penyakit Graves pada populasi Jakarta.

---

Graves' disease is an autoimmune disease in which TSH-R antibodies stimulate the thyroid gland, resulting in excess thyroid hormone synthesis and secretion. 50% patients with graves’ disease relapse after finishing antithyroid drugs treatment. Genetics factor such as FCRL3 rs7528684 SNP contribute to the development of Graves' disease. However no study has yet identified an association of the FCRL3 rs7528684 SNP with Graves' disease recurrence. Therefore, this study aims to determine the association between the genetic polymorphism of FCRL3 rs7528684 and the recurrence of Graves' Disease. This cross-sectional clinical study was performed in 80 Graves' disease patients. DNAs of GD patients were isolated and then genotyped using tetra primer ARMS-PCR method. There are two genotype variations in patients with Graves' Disease, namely GG genotype (2,5%) and GA genotype (97,5%). In the relapsed group, 100% had the GA genotype, so the frequencies of G allotype and A allotype were 50% each. Meanwhile, in the remission group, there are 6,1% GG genotype and 93,9% GA genotype with G and A allotype frquencies were 53,03% and 46,97%, respectively. Based on statistic tests analysis, there is no association between the genotype and allotype of the FCRL3 rs7528684 SNP and Graves' disease recurrence in Jakarta's population."